|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 793.7 INR | -0.03% |
|
-5.47% | -8.64% |
| May. 10 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
| May. 08 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
Fredun Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 481.25 million compared to INR 448.2 million a year ago. Revenue was INR 484.17 million compared to INR 452.49 million a year ago.
Net income was INR 9.44 million compared to INR 3.28 million a year ago. Basic earnings per share from continuing operations was INR 2.12 compared to INR 0.82 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.64% | 44.69M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
FREDUN PHARMACEUTICALS LIMITED 
